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Abstract 
A total of 612 nursery pigs (21-d of age; Line 241 × 600; DNA, Columbus, NE) were used in two 44-d 
experiments to determine effects of antibiotic or different probiotic products on nursery pig performance 
and fecal consistency. In Experiment 1, 297 pigs (initially 12.8 lb) were used with 6 replications per 
treatment and 5 or 6 pigs per pen. In Experiment 2, 315 pigs (initially 13.3 lb) were used with 7 
replications per treatment and 5 pigs per pen. In both experiments, pens were randomly allotted to 1 of 9 
dietary treatments in a randomized complete block design. The nine treatment diets included a control 
diet, or the control diet with either carbadox (Mecadox-2.5 Phibro Animal Health, Teaneck, NJ) at 50 g/ton, 
BioPlus 2B (Chr. Hansen USA, Inc., Milwaukee, WI) with an inclusion rate of 0.05%, or 1 of 6 DSM Probiotic 
products (DSM Nutritional Products, Inc., Parsippany, NJ) with an inclusion rate of 0.20%. 
For Experiment 1, pigs fed the diet containing carbadox had increased (P < 0.05) ADG compared to pigs 
fed the control diet or diets containing DSM Probiotic 1, 2, 3, or 6, with the other probiotic treatments 
intermediate. Pigs fed the diet with carbadox had greater (P < 0.05) ADFI compared to those fed the 
control or diets containing DSM Probiotic 1, 2, or 3, with the other probiotic treatments intermediate. Feed 
efficiency was not affected by treatment. For fecal consistency, there was no evidence to indicate a 
treatment effect (P > 0.05) or treatment × day interaction (P = 0.951). 
For Experiment 2, pigs fed carbadox had greater (P < 0.05) ADG than all other treatments. Pigs fed 
BioPlus 2B had greater (P < 0.05) ADG compared to those fed the diet containing DSM Probiotic 3, with 
the control and all other probiotic treatments intermediate. Pigs fed carbadox had increased (P < 0.05) 
ADFI compared to the control and DSM Probiotics, with BioPlus 2B intermediate. There was no evidence 
of difference to indicate that dietary treatment influenced F/G nor to indicate a treatment effect for fecal 
consistency. 
In summary, pigs fed diets containing carbadox consistently had increased ADG and ADFI compared to 
pigs fed any of the other dietary treatments. There was no evidence the probiotics improved performance 
based on these results; however, the DSM probiotic 4 had the highest numerical ADG of all the DSM 
products relative to the nonmedicated control diet in both experiments. 
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Effects of Antimicrobial or Probiotic 
Treatments on Growth Performance 
of 13- to 56-lb Nursery Pigs 
D.J. Shawk, B.J. Feehan, O.L. Harrison, J.C. Woodworth, M.D. Tokach, 
R.D. Goodband, S.S. Dritz,1 J.M. DeRouchey, N.E. Ward, and A.B. Clark
Summary
A total of 612 nursery pigs (21-d of age; Line 241 × 600; DNA, Columbus, NE) were 
used in two 44-d experiments to determine effects of antibiotic or different probiotic 
products on nursery pig performance and fecal consistency. In Experiment 1, 297 pigs 
(initially 12.8 lb) were used with 6 replications per treatment and 5 or 6 pigs per pen. 
In Experiment 2, 315 pigs (initially 13.3 lb) were used with 7 replications per treatment 
and 5 pigs per pen. In both experiments, pens were randomly allotted to 1 of 9 dietary 
treatments in a randomized complete block design. The nine treatment diets included 
a control diet, or the control diet with either carbadox (Mecadox-2.5 Phibro Animal 
Health, Teaneck, NJ) at 50 g/ton, BioPlus 2B (Chr. Hansen USA, Inc., Milwaukee, 
WI) with an inclusion rate of 0.05%, or 1 of 6 DSM Probiotic products (DSM Nutri-
tional Products, Inc., Parsippany, NJ) with an inclusion rate of 0.20%. 
For Experiment 1, pigs fed the diet containing carbadox had increased (P < 0.05) ADG 
compared to pigs fed the control diet or diets containing DSM Probiotic 1, 2, 3, or 6, 
with the other probiotic treatments intermediate. Pigs fed the diet with carbadox had 
greater (P < 0.05) ADFI compared to those fed the control or diets containing DSM 
Probiotic 1, 2, or 3, with the other probiotic treatments intermediate. Feed efficiency 
was not affected by treatment. For fecal consistency, there was no evidence to indicate a 
treatment effect (P > 0.05) or treatment × day interaction (P = 0.951).
For Experiment 2, pigs fed carbadox had greater (P < 0.05) ADG than all other treat-
ments. Pigs fed BioPlus 2B had greater (P < 0.05) ADG compared to those fed the diet 
containing DSM Probiotic 3, with the control and all other probiotic treatments inter-
mediate. Pigs fed carbadox had increased (P < 0.05) ADFI compared to the control and 
DSM Probiotics, with BioPlus 2B intermediate. There was no evidence of difference 
to indicate that dietary treatment influenced F/G nor to indicate a treatment effect for 
fecal consistency.
1 Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State 
University.
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In summary, pigs fed diets containing carbadox consistently had increased ADG and 
ADFI compared to pigs fed any of the other dietary treatments. There was no evidence 
the probiotics improved performance based on these results; however, the DSM pro-
biotic 4 had the highest numerical ADG of all the DSM products relative to the non-
medicated control diet in both experiments. 
Introduction
Antimicrobials have been commonly used in nursery pig diets to promote ADG and 
ADFI. Antibiotics such as carbadox (Mecadox, Phibro Animal Health, Teaneck, NJ) 
have shown to improve growth and feed intake.2 With changing public perception of 
feed grade antibiotics, new technology has been introduced to potentially replace the 
growth promoting effects of antimicrobials. 
Probiotics have been shown to improve gut health by modifying the microflora in the 
gut and improving nutrient availability.2 BioPlus 2B (Chr. Hansen USA, Inc., Milwau-
kee, WI) is a commercially available probiotic. Wang et al.3 observed that nursery pigs 
fed diets containing BioPlus 2B tended to have improved ADG as the inclusion rate 
of Bioplus 2B increased up to 0.20%. DSM Nutritional Products, Inc. (Parsippany, 
NJ) has developed a series of new probiotic products for potential use in swine diets; 
however, their impact on growth performance has not been evaluated. Therefore, the 
objective of this experiment was to compare the growth performance of nursery pigs fed 
an antimicrobial, or diets containing different experimental probiotic products.
Procedures
The Kansas State University Institutional Animal Care and Use Committee approved 
the protocol used in these experiments. Two experiments were conducted at the Kansas 
State University Swine Teaching and Research Center in Manhattan, KS. Each pen was 
equipped with a 4-hole, dry self-feeder and a nipple waterer to provide ad libitum access 
to feed and water. 
All experimental diets were manufactured at the Kansas State University O.H. Kruse 
Feed Technology Innovation Center, Manhattan, KS. Dietary treatments were corn-
soybean meal-based. Treatment diets were fed in three phases with dietary phases 
formulated for 12 to 15, 15 to 26, and 26 to 55 lb BW ranges (Table 1). The nine treat-
ment diets in both experiments included a control diet, or the control diet with either 
carbadox (Mecadox-2.5; Phibro Animal Health, Teaneck, NJ) at 50 g/ton, BioPlus 2B 
(Chr. Hansen USA, Inc., Milwaukee, WI) with an inclusion rate of 0.05%, or 1 of 6 
DSM Probiotic products (DSM Nutritional Products, Inc., Parsippany, NJ) with an 
inclusion rate of 0.20% (Table 1). BioPlus 2B and the DSM Probiotics were added to 
diets at manufacturer’s recommendations. Diet samples were collected at the mill and 
from feeders and subsampled. Subsamples were analyzed for DM, CP, Ca, and P (Ward 
Laboratories, Inc., Kearney, NE).
2 T.P. Keegan, J.M. DeRouchey, J.L Nelssen, M.D. Tokach, R.D. Goodband, S.S. Dritz, and 
C.W. Hasted. 2003. Comparison of antimicrobial alternatives in diets for nursery pigs. Kansas Swine 
Industry Day Report of Progress 920.
3 Y. Wang, J.H. Cho, Y.J. Chen, J.S. Yoo, Y. Huang, H.J. Kim, I.H. Kim, The effect of probiotic BioPlus 
2B® on growth performance, dry matter and nitrogen digestibility and slurry noxious gas emission in 
growing pigs. 2009 Livestock Science. 1871-1413.
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In both experiments, pigs (Line 241 × 600; DNA, Columbus, NE) were weaned at 21-d 
of age and used in 44-d experiments. Fecal scoring of pens occurred by visual assessment 
of the pen floor. Fecal scores were recorded prior to weighing the pens on each weigh 
day and were replicated by 3 individuals each day. Pens were scored on a scale from 0 to 
3 with 0 indicating firm, dry feces; 1 indicating soft, moist feces; 2 indicating shapeless, 
moist feces; and 3 indicating liquid feces. 
Experiment 1 
A total of 297 pigs were allotted to pens based on gender and BW with 6 replications 
per treatment with 3 replications having 5 pigs and 3 replications with 6 pigs per pen. 
Pens of pigs were weighed and feed disappearance recorded on d 12, 19, 25, 32, 39, and 
44 to determine ADG, ADFI, and F/G. 
Experiment 2 
A total of 315 pigs were allotted to pens of 5 based on gender and BW with 7 replica-
tions per treatment. Pens of pigs were weighed and feed disappearance recorded on d 
11, 18, 25, 32, 39, and 44 to determine ADG, ADFI, and F/G. 
Growth data and fecal consistency scores for both experiments were analyzed as a com-
pletely randomized block design using PROC GLIMMIX in SAS version 9.4 (SAS In-
stitute, Inc., Cary, NC) with pen as the experimental unit. Day and treatment interac-
tions were tested for fecal consistency scores. Individual treatment means of the growth 
and fecal consistency data were separated using the Tukey-Kramer multiple comparison 
test. In Experiment 1, one pen of pigs fed DSM Probiotic 4 was considered an outlier 
due to health concerns and was removed from the data set. Results were considered 
significant at P ≤ 0.05 and marginally significant between P > 0.05 and P ≤ 0.10.
Results and Discussion
For Experiments 1 and 2, chemical analyses indicated that Ca, P, and CP of the treat-
ment diets were similar to formulated values (Tables 2 and 3). 
Experiment 1 
From d 0 to 12, there was no evidence of difference to indicate that dietary treatment 
affected ADG, ADFI, F/G, and d 12 BW (Table 4). 
From d 12 to 25, pigs fed the control diet or diets containing DSM Probiotic 1, 2, 3, 
5, or 6 had decreased (P < 0.05) ADG compared to pigs fed the diet with carbadox, 
with pigs fed the BioPlus 2B and DSM Probiotic 4 diets intermediate. Pigs fed the diet 
with carbadox had greater (P < 0.05) ADFI compared to the control or pigs fed diets 
containing DSM Probiotic 1, 2, or 3, with the other probiotic treatments intermediate. 
Feed efficiency was not affected by treatment. Pigs fed the control or diets containing 
DSM Probiotic 1, 2, 3, or 6 had decreased (P < 0.05) d 25 BW compared to pigs fed the 
diet containing carbadox, with the others intermediate.
From d 25 to 44, pigs fed the diet with carbadox had greater (P < 0.05) ADFI com-
pared to pigs fed the diet containing DSM Probiotic 2, with all others intermediate. 
There was no evidence of difference to indicate that dietary treatment influenced ADG 
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or F/G. Pigs fed the control or diets containing DSM Probiotic 1, 2, 3, or 6 had de-
creased (P < 0.05) d 44 BW compared to pigs fed carbadox, with others intermediate. 
Overall, pigs fed the diet containing carbadox had greater (P < 0.05) ADG compared 
to pigs fed the control diet or diets containing DSM Probiotic 1, 2, 3, or 6, with pigs fed 
probiotic treatments 4 or 5 intermediate. Pigs fed the diet with carbadox had greater 
(P < 0.05) ADFI compared to the control or pigs fed diets containing DSM Probiotic 
1, 2, or 3, with the other probiotics treatments intermediate. Feed efficiency was not 
affected by treatment. 
For fecal consistency, there was no evidence of difference to indicate a treatment effect 
or a treatment × day interaction. However, there was a day effect observed (P < 0.001; 
Table 6) with pigs exhibiting softer stools on d 12, 19, and 25 and firmer stools on d 32, 
39, and 44.
Experiment 2 
From d 0 to 11, pigs fed the diet containing carbadox had greater (P < 0.05) ADG than 
pigs fed the other dietary treatments (Table 5). Pigs fed the control or DSM Probiotic 
1, 2, 3, or 5 had decreased (P < 0.05) ADFI compared to pigs fed carbadox, with pro-
biotic treatments 4 and 6 intermediate. There was no evidence of difference to indicate 
dietary treatment affected F/G. Pigs fed carbadox had greater (P < 0.05) d 11 BW than 
pigs fed the control or DSM Probiotic 1, 3, or 5, with others probiotic treatments inter-
mediate. 
From d 11 to 25, pigs fed the diet containing carbadox had greater (P < 0.05) ADG 
compared to pigs fed the control or the DSM Probiotics, with pigs fed BioPlus 2B 
intermediate. Pigs fed the control or DSM Probiotic 3, 5, or 6 had lower (P < 0.05) 
ADFI compared to pigs fed carbadox, with others intermediate. No treatment effect 
was observed for F/G. Pigs fed carbadox had greater (P < 0.05) d 25 BW than pigs fed 
other treatments. 
From d 25 to 44, pigs fed carbadox had greater (P < 0.05) ADG and ADFI compared 
to those fed the control or DSM Probiotics with those fed BioPlus 2B intermediate. 
Feed efficiency was not affected by dietary treatment. Pigs fed carbadox had greater 
(P < 0.05) d 44 BW than pigs fed other treatments.
Overall, pigs fed carbadox had greater (P < 0.05) ADG than all other treatments. Pigs 
fed BioPlus 2B had greater (P < 0.05) ADG compared to the DSM Probiotic 3 treat-
ment, with the control and all other probiotic treatments intermediate. Pigs fed carba-
dox had improved (P < 0.05) ADFI compared to pigs fed the control or DSM Probiot-
ics, with BioPlus 2B intermediate. There was no evidence of difference to indicate that 
dietary treatment influenced F/G. For final BW, pigs fed carbadox were 12 lb heavier 
(P < 0.05) than those fed the control diet.
For fecal consistency, there was a tendency for a treatment × day interaction 
(P = 0.084; Table 7) with pigs fed DSM Probiotic 4 exhibiting lower fecal scores until 
d 18 and pigs fed DSM Probiotic 3 exhibiting higher fecal scores until d 18 but both 
products having similar fecal scores from d 25 to 44. There was no evidence of differ-
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ence between other dietary treatments. The day of collection did affect (P < 0.001) fecal 
consistency with pigs exhibiting softer stools on d 18, 32, and 39 and firmer stools on d 
25.
In conclusion, pigs fed carbadox consistently had improved ADG and ADFI compared 
to pigs fed other probiotics. In both experiments, pigs fed DSM probiotic 4 had nu-
merical improvements in ADG compared to pigs fed the other DSM probiotics and 
the control. This study would indicate that DSM Probiotic 4 merits further research to 
determine the repeatability of response and optimal dose and duration of feeding.
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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Table 1. Diet composition (Experiments 1 and 2, as-fed basis)1
Ingredient, % Phase 1 Phase 2 Phase 3
Corn 39.93 52.75 62.88
Soybean meal 19.73 29.14 32.56
Fish meal 6.00 4.00 ---
Dried whey 12.50 5.00 ---
Dairylac 802 11.25 5.00 ---
HP 3003 6.00 --- ---
Choice white grease 2.00 1.00 1.00
Limestone 0.38 0.58 0.95
Monocalcium phosphate, 21% P 0.60 0.80 1.18
Sodium chloride 0.35 0.55 0.35
L-Lys HCl 0.35 0.35 0.35
DL-Met 0.21 0.18 0.15
L-Thr 0.17 0.16 0.13
L-Trp 0.02 0.02 0.01
L-Val 0.08 0.07 0.04
Choline chloride, 60% 0.04 --- ---
Phytase4 0.02 0.02 0.02
Trace mineral premix 0.15 0.15 0.15
Vitamin premix 0.25 0.25 0.25
Feed additive5,6,7 --- --- ---
Total 100 100 100
continued
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Table 1, continued. Diet composition (Experiments 1 and 2, as-fed basis)1
Ingredient, % Phase 1 Phase 2 Phase 3
Calculated analysis
Standardized ileal digestible (SID) AA,8 %
Lys 1.40 1.35 1.25
Ile:Lys 59 59 61
Leu:Lys 112 117 125
Met:Lys 39 37 35
Met and Cys:Lys 58 58 58
Thr:Lys 63 63 62
Trp:Lys 18.5 18.5 18.5
Val:Lys 69 69 69
Total Lys, % 1.56 1.51 1.40
NE kcal/lb 1,180 1,130 1,113
CP, % 22.3 22.1 21.3
Ca, % 0.74 0.71 0.70
P, % 0.72 0.68 0.65
Available P, % 0.57 0.49 0.42
1 Experimental diets were fed in three phases with dietary phases formulated for 12 to 15, 15 to 26, and 26 to 55 lb 
BW ranges.
2 International Ingredients, Inc., St. Louis, MO.
3 Hamlet Protein, Findlay, OH.
4 HiPhos 2700 (DSM Nutritional Products, Inc., Parsippany, NJ), providing 184.3 phytase units (FTU)/lb and 
an estimated release of 0.10% available P.
5 Mecadox-2.5 (Phibro Animal Health, Teaneck, NJ) included at 1% to add 50 g/ton of carbadox.
6 BioPlus 2B (Chr. Hansen USA, Inc., Milwaukee, WI) included at 0.05% at the expense of corn.
7 Experimental probiotics 1 to 6 (DSM Nutritional Products, Inc., Parsippany, NJ) included at 0.20% at the 
expense of corn.
8 AA = amino acids.
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Item, % Control Mecadox2 1 2 3 4 5 6
Phase 1 diets 
DM 90.39 90.43 91.48 90.99 90.85 91.47 91.29 91.79 90.90
CP 21.7 22.1 21.3 21.6 22.1 22.2 22.0 21.7 21.9
Ca 1.07 1.17 1.12 1.10 1.18 1.10 1.08 1.06 1.17
P 0.76 0.82 0.78 0.74 0.79 0.77 0.76 0.74 0.80
Phase 2 diets 
DM 89.76 89.89 89.00 89.26 89.99 89.44 90.47 89.36 89.93
CP 20.9 21.9 21.6 20.3 19.3 21.1 20.4 22.3 21.5
Ca 1.03 0.86 0.93 1.08 1.04 0.96 1.05 0.96 1.01
P 0.75 0.66 0.64 0.76 0.69 0.70 0.75 0.71 0.72
Phase 3 diets 
DM 88.73 88.11 89.64 88.92 88.92 89.12 88.00 88.51 88.83
CP 20.9 20.4 19.5 19.2 21.5 20.1 21.2 20.3 20.0
Ca 0.87 0.90 0.97 1.00 0.81 0.98 0.77 0.92 0.77
P 0.63 0.59 0.64 0.67 0.59 0.63 0.57 0.65 0.56
1 Multiple samples were collected from each diet throughout the study, homogenized, and then subsampled for analysis (Ward 
Laboratories, Inc., Kearney, NE).
2 Mecadox-2.5 (Phibro Animal Health, Teaneck, NJ).
3 BioPlus 2B (Chr. Hansen USA, Inc., Milwaukee, WI).
4 Experimental probiotics (DSM Nutritional Products, Inc., Parsippany, NJ).
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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Item, % Control Mecadox2 1 2 3 4 5 6
Phase 1 diets 
DM 91.97 91.48 91.99 90.89 91.25 90.84 91.76 91.37 91.42
CP 21.9 21.6 22.8 22.0 22.8 22.0 22.5 22.1 23.5
Ca 1.16 1.09 1.15 1.12 1.23 1.21 1.20 1.14 1.18
P 0.82 0.79 0.81 0.79 0.83 0.83 0.85 0.81 0.80
Phase 2 diets 
DM 89.29 89.96 90.74 89.81 89.93 90.03 89.86 90.67 90.12
CP 21.4 19.6 20.1 20.8 21.5 20.5 22.3 19.3 20.1
Ca 1.02 0.93 1.05 0.92 1.06 1.01 1.02 1.10 0.96
P 0.72 0.65 0.69 0.66 0.73 0.69 0.75 0.69 0.70
Phase 3 diets 
DM 89.03 88.64 88.87 88.74 88.56 90.09 90.41 89.62 89.82
CP 22.4 21.4 21.1 22.1 19.1 22.7 22.6 20.8 22.3
Ca 0.95 0.77 0.81 0.85 1.05 0.85 1.03 0.90 0.71
P 0.61 0.53 0.57 0.62 0.56 0.64 0.66 0.60 0.61
1 Multiple samples were collected from each diet throughout the study, homogenized, and then subsampled for analysis  
(Ward Laboratories, Inc., Kearney, NE).
2 Mecadox-2.5 (Phibro Animal Health, Teaneck, NJ).
3 BioPlus 2B (Chr. Hansen USA, Inc., Milwaukee, WI).
4 Experimental probiotics (DSM Nutritional Products, Inc., Parsippany, NJ).
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Item Control Mecadox2 1 2 3 4 5 6 SEM5
d 0 to 12 (phase 1)
ADG, lb 0.17 0.26 0.17 0.19 0.16 0.16 0.21 0.18 0.18 0.021
ADFI, lb 0.34 0.42 0.33 0.34 0.35 0.34 0.38 0.37 0.36 0.021
F/G 2.19 1.64 2.17 1.84 2.27 2.23 1.82 2.17 2.01 0.173
d 12 to 25 (phase 2)
ADG, lb 0.84b 1.13a 0.96ab 0.87b 0.87b 0.88b 0.99ab 0.94b 0.92b 0.041
ADFI, lb 1.12b 1.51a 1.27ab 1.13b 1.14b 1.24b 1.32ab 1.31ab 1.27ab 0.061
F/G 1.34 1.34 1.32 1.31 1.32 1.41 1.35 1.39 1.37 0.039
d 25 to 44 (phase 3) 
ADG, lb 1.34 1.48 1.38 1.28 1.29 1.32 1.42 1.37 1.30 0.050
ADFI, lb 2.03ab 2.32a 2.11ab 2.01ab 1.99b 2.03ab 2.21ab 2.14ab 2.03ab 0.079
F/G 1.52 1.56 1.53 1.58 1.55 1.54 1.55 1.56 1.56 0.025
d 0 to 44
ADG, lb 0.87b 1.04a 0.93ab 0.86b 0.85b 0.88b 0.96ab 0.91ab 0.88b 0.033
ADFI, lb 1.29b 1.56a 1.38ab 1.29b 1.28b 1.34b 1.45ab 1.40ab 1.35ab 0.051
F/G 1.50 1.49 1.49 1.50 1.51 1.53 1.50 1.54 1.53 0.023
BW, lb
d 0 12.8 12.8 12.8 12.8 12.8 12.8 12.8 12.8 12.8 0.212
d 12 14.8 15.9 14.8 15.1 14.8 14.8 15.4 15.1 15.1 0.377
d 25 25.6b 30.6a 27.3ab 26.5b 26.1b 26.2b 28.2ab 27.3ab 27.0b 0.750
d 44 51.1b 58.7a 53.5ab 51.3b 52.3b 51.4b 55.2ab 53.4ab 51.8b 1.324
Fecal consistency6 1.19 1.08 1.08 1.21 1.21 1.29 1.17 1.35 1.47 0.112
ab Means with different superscripts differ P < 0.05.
1 A total of 297 pigs (Line 241 × 600; DNA, Columbus, NE; 21 d of age) were used in a 44-d with 6 replications per treatment. 
2 Mecadox-2.5 (Phibro Animal Health, Teaneck, NJ) fed at 50 g/ton.
3 Bioplus 2B (Chr. Hansen USA, Inc., Milwaukee, WI).
4 Experimental probiotics (DSM Nutritional Products, Inc., Parsippany, NJ).
5 SEM = standard error of the mean.
6 Fecal scores were recorded prior to weighing the pens on each weigh day and were replicated by 3 individuals each day; those scores were then aver-
aged and reported as the pen means for the overall and each collection day. Pens were scored on a scale from 0-3 with 0 indicating firm, dry feces; 1 
indicating soft, moist feces; 2 indicating shapeless, moist feces; and 3 indicating liquid feces.
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Item Control Mecadox2 1 2 3 4 5 6 SEM5
d 0 to 11 (phase 1)
ADG, lb 0.11b 0.33a 0.15b 0.13b 0.16b 0.11b 0.17b 0.10b 0.17b 0.029
ADFI, lb 0.24b 0.41a 0.29ab 0.26b 0.27b 0.22b 0.32ab 0.25b 0.29ab 0.028
F/G 6.93 1.26 2.09 1.40 1.93 3.41 2.09 3.10 1.84 1.745
d 11 to 25 (phase 2)
ADG, lb 0.86b 1.09a 0.92ab 0.86b 0.85b 0.79b 0.88b 0.83b 0.84b 0.040
ADFI, lb 1.14b 1.44a 1.23ab 1.23ab 1.20ab 1.11b 1.21ab 1.11b 1.16b 0.058
F/G 1.33 1.32 1.34 1.43 1.41 1.41 1.38 1.34 1.40 0.039
d 25 to 44 (phase 3) 
ADG, lb 1.43b 1.78a 1.60ab 1.51b 1.47b 1.42b 1.51b 1.48b 1.48b 0.047
ADFI, lb 2.24b 2.80a 2.54ab 2.34b 2.35b 2.30b 2.42b 2.40b 2.39b 0.077
F/G 1.56 1.57 1.59 1.55 1.61 1.63 1.61 1.63 1.63 0.032
d 0 to 44
ADG, lb 0.91cb 1.20a 1.02b 0.96cb 0.94cb 0.87c 0.97cb 0.93cb 0.95cb 0.034
ADFI, lb 1.37b 1.77a 1.56ab 1.47b 1.45b 1.37b 1.51b 1.45b 1.48b 0.050
F/G 1.51 1.48 1.53 1.53 1.55 1.58 1.55 1.57 1.56 0.027
BW, lb
d 0 13.3 13.3 13.3 13.3 13.3 13.3 13.2 13.3 13.3 0.309
d 11 14.5b 17.0a 15.1ab 14.8b 15.0ab 14.6b 15.3ab 14.4b 15.1ab 0.465
d 25 26.7b 32.3a 28.0b 26.7b 26.9b 25.7b 27.4b 26b 26.9b 0.864
d 44 54.0b 66.0a 58.4b 55.5b 54.8b 53.3b 56.0b 54.1b 54.9b 1.461
Fecal consistency6 1.46 1.25 1.39 1.44 1.33 1.56 1.29 1.55 1.37 0.070
abcd Means with different superscripts differ P < 0.05.
1 A total of 315 pigs (Line 241 × 600; DNA, Columbus, NE) were used in a 44-d study with 5 pigs per pen and 7 pens per treatment. 
2 Mecadox-2.5 (Phibro Animal Health, Teaneck, NJ) fed at 50 g/ton.
3 BioPlus 2B (Chr. Hansen USA, Inc., Milwaukee, WI).
4 Experimental probiotics (DSM Nutritional Products, Inc., Parsippany, NJ).
5 SEM = standard error of the mean.
6 Fecal scores were recorded prior to weighing the pens on each weigh day and were replicated by 3 individuals each day; those scores were 
then averaged and reported as the pen means for the overall and each collection day. Pens were scored on a scale from 0-3 with 0 indicating 
firm, dry feces; 1 indicating soft, moist feces; 2 indicating shapeless, moist feces; and 3 indicating liquid feces.
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Table 6. Nursery fecal consistency over time, Experiment 1 







ab Means with different superscripts differ P < 0.05. Treatment × Day interaction (P = 0.951) and day effect 
(P < 0.001).
1 Fecal scores were recorded prior to weighing the pens and were replicated by 3 individuals each day; those scores 
were then averaged and reported as the pen means for the overall and each collection day. Pens were scored on a 
scale from 0-3 with 0 indicating firm, dry feces; 1 indicating soft, moist feces; 2 indicating shapeless, moist feces; 
and 3 indicating liquid feces. 








ab Means with different superscripts differ P < 0.05. Treatment × Day interaction (P = 0.084) and day effect  
(P < 0.001).
1 Fecal scores were recorded prior to weighing the pens on each weigh day and were replicated by 3 individuals 
each day; those scores were then averaged and reported as the pen means for the overall and each collection day. 
Pens were scored on a scale from 0-3 with 0 indicating firm, dry feces; 1 indicating soft, moist feces; 2 indicating 
shapeless, moist feces; and 3 indicating liquid feces. 
